Liver Tumor Therapy Company HistoSonics Valued at $2.25 Billion in Sale

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

Investors Back Cancer Ultrasound Tech Firm At $2.25B Value

PharmaCann Raises $39.5 Million Selling Additional 12% Senior Secured Notes

Fox Rothschild Guides PetVivo Holdings in $11.25 Million IPO

A South Florida Litigator is Helping His Firm’s Lawyers Feel Connected Amid the Pandemic

Fox Rothschild Real Estate Team Closes on $63 Million Palm Beach Commercial Property Purchase